Cardio-oncology Issues in Lymphoma Patients

被引：0
作者：
Bryne, Alex [1 ]
Lambert, Jonathan [2 ]
Yellon, Derek [3 ]
Walker, Malcolm [3 ]
Sivabalasingham, Suganya [2 ]
Ghosh, Arjun K. [2 ,3 ]
机构：
[1] Royal Surrey Cty Hosp, Guildford, Surrey, England
[2] St Bartholomews Hosp West Smithfield, Barts Heart Ctr, London EC1A 7BE, England
[3] UCL, Hatter Cardiovasc Inst, London, England
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2022年 / 24卷 / 03期
关键词：
cardiology; cardiotoxicity; lymphoma; oncology; pre-assessment; T-CELL THERAPY; RISK; DISEASE; CANCER; RADIOTHERAPY; SURVIVORS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Advances in Lymphoma management have resulted in significant improvements in patient outcomes over the last 50 years. Despite these developments, cardiotoxicity from lymphoma treatments remains an important cause of mortality and morbidity in this cohort of patients. We reviewed the most common cardiotoxicities associated with lymphoma treatments and their respective investigation and management strategies, including the role of cardiac pre-assessment and late effects monitoring.
引用
收藏
页码：159 / 164
页数：6
相关论文
共 39 条
  • [1] Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines
    Alexandre, Joachim
    Cautela, Jennifer
    Ederhy, Stephane
    Damaj, Ghandi Laurent
    Salem, Joe-Elie
    Barlesi, Fabrice
    Farnault, Laure
    Charbonnier, Aude
    Mirabel, Mariana
    Champiat, Stephane
    Cohen-Solal, Alain
    Cohen, Ariel
    Dolladille, Charles
    Thuny, Franck
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
  • [2] [Anonymous], 2018, CURR TREAT OPTION CA
  • [3] Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
    Armstrong, Gregory T.
    Oeffinger, Kevin C.
    Chen, Yan
    Kawashima, Toana
    Yasui, Yutaka
    Leisenring, Wendy
    Stovall, Marilyn
    Chow, Eric J.
    Sklar, Charles A.
    Mulrooney, Daniel A.
    Mertens, Ann C.
    Border, William
    Durand, Jean-Bernard
    Robison, Leslie L.
    Meacham, Lillian R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3673 - +
  • [4] Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?
    Aznar, Marianne C.
    Maraldo, Maja V.
    Schut, Deborah A.
    Lundemann, Michael
    Brodin, N. Patrik
    Vogelius, Ivan R.
    Berthelsen, Anne K.
    Specht, Lena
    Petersen, Peter M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 169 - 174
  • [5] Cardiovascular Toxicities of Immune Checkpoint Inhibitors JACC Review Topic of the Week
    Ball, Somedeb
    Ghosh, Raktim K.
    Wongsaengsak, Sariya
    Bandyopadhyay, Dhrubajyoti
    Ghosh, Gopal Chandra
    Aronow, Wilbert S.
    Fonarow, Gregg C.
    Lenihan, Daniel J.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : 1716 - 1727
  • [6] Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding
    Boriani, Giuseppe
    Corradini, Paolo
    Cuneo, Antonio
    Falanga, Anna
    Foa, Robin
    Gaidano, Gianluca
    Ghia, Paolo Prospero
    Martelli, Maurizio
    Marasca, Roberto
    Massaia, Massimo
    Mauro, Francesca Romana
    Minotti, Giorgio
    Molica, Stefano
    Montillo, Marco
    Pinto, Antonio
    Tedeschi, Alessandra
    Vitolo, Umberto
    Zinzani, Pier Luigi
    [J]. HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 624 - 632
  • [7] Breiman L., 2001, Machine Learning, V45, P5
  • [8] Cutter DJ, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/djv008, 10.1016/j.asams.2015.03.009]
  • [9] Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management
    Dhesi, Sumandeep
    Chu, Michael P.
    Blevins, Gregg
    Paterson, Ian
    Larratt, Loree
    Oudit, Gavin Y.
    Kim, Daniel H.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2013, 1 (01):
  • [10] Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen
    Dlugosz-Danecka, Monika
    Gruszka, Alicja M.
    Szmit, Sebastian
    Olszanecka, Agnieszka
    Ogorka, Tomasz
    Sobocinski, Marcin
    Jaroszynski, Andrzej
    Krawczyk, Katarzyna
    Skotnicki, Aleksander B.
    Jurczak, Wojciech
    [J]. CHEMOTHERAPY, 2018, 63 (04) : 238 - 245
1234